Harvest One Extends Cannabis Operations by Securing Dealer’s License

 

United Greeneries receives Dealer’s License to allow for imports and exports of cannabis products and establishing of product development platform

VANCOUVER, June 18, 2018 /CNW/ – Harvest One Cannabis Inc. (TSXV: HVT) (“Harvest One” or the “Company”) is pleased to advise that its wholly owned subsidiary, United Greeneries (“United Greeneries” or “UG”), has received a Dealer’s License pursuant to the Controlled Drugs and Substances Act under Health Canada.

The license now allows UG to import narcotics into Canada, including its signature Gelpell Microgel CBD capsules that are produced in Switzerland and that are already sold as a nutritional supplement in the European Union and as a prescription drug in Australia.

The Dealer’s License further allows the Company to export its medical cannabis products to other markets with favourable medical marijuana regulations, including Germany.

With this license, the Company will also further engage in research and development of cannabis infused products and is preparing a state-of-the art product development centre at its Duncan facility in British Columbia, planning to soon offer several value-add services to the industry, including a full quality control laboratory and co-packaging.

Securing our Dealer’s License is a significant milestone for United Greeneries and Harvest One. This is an important step in supplying our Satipharm products to Canadian consumers and also allows us to expedite the development of Dream Water’s CBD infused product line. We will be expanding our global presence and leveraging Satipharm’s supply agreements to bring our products to international markets.

Andreas Gedeon, CEO of Harvest One

About Harvest One Cannabis Inc. (TSXV: HVT)
Harvest One is a global cannabis company focused on delivering high quality, innovative cannabis products and technology to regulated markets around the world. Shareholders have significant exposure to the entire cannabis value chain through three wholly owned operating subsidiaries: Horticultural arm and Canadian Licensed Producer United Greeneries Ltd., medical and pharmaceutical arm Satipharm AG in Switzerland and Dream Water Global, the Group’s consumer goods division.

Original press release

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter